Zing Open Zing
Economy

Rocket Lab Stock Surges 34% on Record Earnings, Major Defense Contracts

9 May 2026 · Source balance: Centre

Rocket Lab stock surged approximately thirty-four percent on May eighth, delivering its best day ever. The company reported first-quarter revenue of two hundred million dollars, beating Wall Street estimates by over ten million, alongside record demand driving a two-point-two-billion-dollar backlog. Beyond earnings, Rocket Lab announced its largest launch contract to date with a confidential customer, signed a thirty-million-dollar hypersonic test contract with defense firm Anduril, and was selected alongside Raytheon to support the U.S. Space Force's Space Based Interceptor program. The company also announced plans to acquire Motiv Space Systems, strengthening its robotics capabilities. Stifel analyst Erik Rasmussen raised his price target to one hundred ten dollars from one hundred five, citing strong execution and a favorable competitive environment with limited direct competition. Management guided second-quarter revenue between two hundred twenty-five and two hundred forty million dollars, above consensus expectations.

Key facts

  • Q1 2026 revenue reached $200.35 million, up 63.5% year-over-year, beating estimates of $189.68 million
  • Rocket Lab's backlog jumped to $2.2 billion, more than double from a year ago
  • Stock jumped 26% to 34% in a single trading session on May 8, 2026
  • Company signed its largest launch contract ever with a confidential customer for Neutron and Electron rockets
  • Secured $30 million contract with Anduril for three HASTE hypersonic test flights
  • Selected with Raytheon to demonstrate capabilities for U.S. Space Force's Space Based Interceptor program
  • Stifel raised price target to $110 from $105, maintaining Buy rating
  • Rocket Lab stock has gained 346.6% over the past year and 2,500% over three years

Limits of this briefing

Sources were primarily from centrist financial media outlets; left-leaning and right-leaning political outlets did not appear to cover this story. Stock is trading at elevated valuations relative to earnings, and execution risks remain on Neutron rocket development.

Sources

More stories

See all latest stories